Business Wire·Nov 10, 2026, 10:00 AM ET

New oncology model from Humana, Evolent and American Oncology Network eliminates prior authorization burden

Humana Inc. launched a new cancer care model in collaboration with Evolent Health & American Oncology Network (AON) across eight states.
The model aims to improve care quality, timeliness, & affordability while reducing reliance on traditional prior authorization.
Participating AON providers with a streamlined process for managing anticancer drug therapies will no longer need to submit prior authorization requests if they adhere to evidence-based treatment standards.
Quality improvement initiatives include periodic patient testing for immunotherapy response & automated EHR reminders to increase adoption of high-value care steps.
Evolent supports the model through oncology clinical pathways, quality improvement programs, & provider performance reporting.
A data-driven analytics platform powered by Meaningful Insights Biotech Analytics (MiBA) leverages real-time EHR data to deliver clinical insights & guide personalized treatment plans.
The initiative builds on a 20-year partnership between Humana & Evolent, including through Evolent's New Century Health business.
AON represents over 350 providers practicing across 21 states & was founded in 2018 to support community oncology viability.